Mature megakaryocytes are large, polyploid bone marrow cells that give rise to circulating platelets (1). Thrombopoietin (TPO) 1 has been characterized as the primary hematopoietic cytokine regulating normal megakaryocyte (MK) development. The receptor for TPO is encoded by the c-mpl proto-oncogene, a member of the hematopoietic growth factor receptor family, which in altered form causes a myeloproliferative syndrome in mice (2). In addition to its effects on MK development, TPO has been found to play a significant role in promoting stem cell survival, and in conjunction with other cytokines, it can support stem cell expansion (3-5). Characterization of the pathways by which TPO signals to promote survival and proliferation in stem cells and developing MKs is critical to a better understanding of the physiologic, pathologic, and potentially therapeutic roles of the cytokine in stem cell expansion, myeloproliferative disorders, and states of bone marrow failure.
Mature megakaryocytes are large, polyploid bone marrow cells that give rise to circulating platelets (1) . Thrombopoietin (TPO) 1 has been characterized as the primary hematopoietic cytokine regulating normal megakaryocyte (MK) development. The receptor for TPO is encoded by the c-mpl proto-oncogene, a member of the hematopoietic growth factor receptor family, which in altered form causes a myeloproliferative syndrome in mice (2) . In addition to its effects on MK development, TPO has been found to play a significant role in promoting stem cell survival, and in conjunction with other cytokines, it can support stem cell expansion (3) (4) (5) . Characterization of the pathways by which TPO signals to promote survival and proliferation in stem cells and developing MKs is critical to a better understanding of the physiologic, pathologic, and potentially therapeutic roles of the cytokine in stem cell expansion, myeloproliferative disorders, and states of bone marrow failure.
Many of the effects of TPO on cell survival and proliferation have been ascribed to activation of the Jak/STAT and Ras/Raf/ MAPK pathways (reviewed in Ref. 6 ). Activation of Jak2 leads to tyrosine phosphorylation of Mpl as well as STAT3 and STAT5 (7, 8) , and the phosphorylated STATs dimerize and translocate to the nucleus, where they stimulate transcription. In addition, phosphorylation of distal tyrosine residues on Mpl creates docking sites for SHC, which undergoes phosphorylation and then recruits Grb2/SOS, thus activating the Ras/Raf/ MAPK pathway (8 -10) . Activation of the Ras/Raf/MAPK pathway can also occur by an alternative, as yet undetermined mechanism, independent of the distal receptor phosphotyrosine residues (11) .
Although these studies and others have shown that activation of the Jak/STAT and Ras/Raf/MAPK pathways is important for signaling by Mpl, other pathways likely contribute to the cellular response to TPO. One such pathway that may contribute to Mpl signaling is phosphatidylinositol 3-kinase (PI3K). PI3K has been shown to be activated by many growth factors involved in hematopoiesis, including stem cell factor, platelet-derived growth factor, erythropoietin, interleukin 3 (IL-3), IL-2, granulocyte-macrophage colony-stimulating factor, granulocyte colony stimulating factor, insulin-like growth factor 1, and TPO (12) (13) (14) (15) (16) . It has been well established that activation of PI3K plays an important role in promoting cell survival (17) (18) (19) . However, although there are ample data supporting a requirement for PI3K in proliferation of nonhematopoietic cells (20 -22) , data showing specific requirements for PI3K in the cytokine-dependent proliferation of hematopoietic cells are inconclusive. Studies in cell lines with IL-2, IL-3, and erythropoietin have supported a role for PI3K in the proliferative response (23) (24) (25) (26) ; however, studies with Flt-3L have not (27) . Importantly, the conclusions from studies performed in primary cells often differ from those performed in cell lines. For example, data from cell lines support the role of PI3K in erythropoietin-induced proliferation (24, 25) , whereas a study done in primary erythroid progenitors concluded that the specific role of PI3K was to promote erythropoietin-induced survival (28) . These studies demonstrate that the role of PI3K in cell proliferation may be cytokine-and cell type-specific. Therefore, in this, work we examined TPO signaling both in a TPOresponsive cell line (BaF3/Mpl) and in primary murine MK progenitors, and we show that an intact PI3K pathway is necessary but not sufficient for cell cycling.
MATERIALS AND METHODS
Cell Lines and Culture Conditions-BaF3/Mpl cells were obtained from Zymogenetics (Seattle, WA) and have been previously described (29) . Mpl expression was verified by FACS using a polyclonal rabbit anti-Mpl (Zymogenetics). BaF3/Mpl cells were cultured in RPMI 1640 medium (BioWhittaker, Walkersville, MD) supplemented with 10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT), 100 units/ml penicillin, 100 g/ml streptomycin, 0.25 g/ml fungizone (BioWhittaker), 2 mM L-glutamine, 20 ng/ml recombinant human TPO (rhTPO) (Zymogenetics), and puromycin (1 g/ml). MyrAktMpl cells were also cultured with G418 (500 g/ml). All cells were cultured at 37°C in 5% CO 2 and 95% air.
Plasmids and Construction of Cell Lines-pcDNA-MyrAkt was the generous gift of Peter Vogt and has been described (30) . BaF3/Mpl cells were transfected with 10 g of plasmid DNA by electroporation and selected in G418 (500 g/ml). A pooled line was obtained (MyrAktMpl). We verified that MyrAktMpl expressed constitutive Akt activity by performing Western blotting for phosphorylated Ser 473 Akt and phosphorylated Ser 9 GSK-3␤ (New England Biolabs) on protein lysates from cells cultured in the absence of TPO, with TPO, or with TPO and LY294002 (data not shown).
Isolation of Mouse MK Progenitors-Isolation of mouse MK progenitors was performed by modification of a protocol described previously (31) . Briefly, BDF-1 female mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice were injected subcutaneously with 2 g of rhTPO for 7 consecutive days prior to bone marrow harvest. Mice were anesthetized by CO 2 narcosis and sacrificed by cervical dislocation, and their femurs and tibiae were removed. Marrow cells from these bones were flushed into CATCH buffer (0.36% sodium citrate, 2 mM theophylline, and 1 mM adenosine in calcium-free Hanks' buffered salt solution) containing 3% BSA, 1 g/ml prostaglandin E 1 (Sigma) and 1 units/ml DNase (Roche Molecular Biochemicals). Red cells were removed by centrifugation through a Optiprep 1.080 (Nycomed, Oslo, Norway) gradient. Lineage depletion was performed using the rat antimouse antibodies 7/4 (Serotec, Raleigh, NC), TER119, CD-5, MAC-1, B220, and GR-1 (Pharmingen, San Diego, CA) followed by incubation with sheep anti-rat IgG magnetic beads (Dynabeads, Dynal, Lake Success, NY). Lineage-positive cells were removed by the application of a magnet, and lineage-negative cells were incubated at 37°C for 1.5 h in IMDM/10% fetal bovine serum containing 10 M Hoechst 33342. These cells were then labeled with phycoerythrin-conjugated anti-CD41 and fluorescein isothiocyanate-conjugated anti-Gr-1 (Pharmingen). The CD41-positive, Gr-1-negative cells were sorted into 2N and 4N populations using a Vantage fluorescence activated cell sorter (Becton-Dickinson San Diego, CA). All procedures involving animals and their care conformed to institutional guidelines.
Purification of Mature Mouse MKs-Mice were injected with rhTPO for 5 days, and marrows were flushed into CATCH buffer as described above. Whole bone marrow cells were cultured for 3 days in IMDM supplemented with 1% Nutridoma (Roche Molecular Biochemicals), fungizone, L-glutamine, and mouse recombinant TPO (5% v/v conditioned medium, about 37.5 ng/ml). Mature MKs were purified over a discontinuous BSA (fraction V, Sigma) density gradient (0/2/4% BSA). By this method, 90% of the cells that settle to the bottom over 40 min are mature MKs (11) .
Stimulation of Cells for Protein Lysates-BaF3/Mpl cells were washed three times in phosphate-buffered saline to remove growth factor and serum. MKs were used as isolated from the discontinuous albumin gradient. Cells were starved for 6 h in RPMI containing Lglutamine, fungizone, and 0.5% BSA. Starved cells were preincubated for 30 min with 16 M LY294002 dissolved in Me 2 SO (Calbiochem, San Diego, CA) or an equivalent volume of Me 2 SO. Cells were then stimulated with rhTPO (250 ng/ml; equivalent to using 25 ng/ml mouse TPO, given the species difference) for 10 min. At the completion of the stimulation, ice-cold phosphate-buffered saline was added and a cell lysate was prepared by Triton X solubilization as previously described (8) .
Western Blotting-Protein concentrations were determined using the Protein/DC assay (Bio-Rad). For each sample, 25 g of total protein was denatured by boiling for 10 min in loading buffer containing 50 l/ml ␤-mercaptoethanol and separated on a 7.5% NaDodSO 4 /polyacrylamide gel electrophoresis minigel (Bio-Rad). Proteins were transferred to a nitrocellulose membrane (Schleicher & Schuell) and blocked for 1 h at room temperature with Tris-buffered saline (pH 8.0) containing 0.05% Tween-20 (TBST) and 5% nonfat dry milk. The membrane was then incubated overnight at 4°C in TBST with 5% milk and a 1:2000 dilution of rabbit polyclonal antibody specific for Akt phosphorylated at Ser 473 (New England Biolabs). After three 10-min washes in TBST, the membrane was incubated in TBST with 5% milk containing a 1:3000 dilution of secondary antibody (goat anti-rabbit, Bio-Rad) for 1 h at room temperature. After three 10 min washes in TBST, the membrane was incubated with chemiluminescent reagents (Lumiglo, New England Biolabs) and exposed to film. After exposure, the antibodies were stripped from the membrane by washing in 62.5 mM Tris (pH 6.8), 2% NaDodSO 4 , and 100 mM ␤-mercaptoethanol at 55°C for 30 min. The blots were then washed with TBST, reblocked, and reprobed using a 1:2000 dilution of polyclonal rabbit antibody recognizing all forms of Akt (New England Biolabs), in order to verify equal loading.
Annexin, Apotag, and BrdUrd Assays-Unsynchronized BaF3/Mpl cells were washed three times in phosphate-buffered saline to remove growth factor and serum and starved for 6 h in RPMI/0.5% BSA. Cells were preincubated for 30 min with 16 M LY294002 and then stimulated with or without 20 ng/ml rhTPO. Cells were cultured for an additional 16 h prior to assay. Primary MK progenitors were effectively starved of growth factors during the ϳ8-h purification process and subsequently plated into fresh IMDM/10% fetal bovine serum containing 16 M LY294002 or the equivalent volume of Me 2 SO, with or without 20 ng/ml rhTPO. Cells were incubated for an additional 12 h prior to assay. At the time of assay, cell cultures were divided into two aliquots. The first aliquot was assayed for apoptotic cells using either Annexin V or Apotag (both obtained from Pharmingen). For Annexin V assays, cells incubated in Annexin V binding buffer (10 mM HEPES/ NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) with 0.2 l/ml Annexin V conjugated to fluorescein isothiocyanate (Pharmingen) for 15 min. The cells were then fixed in 80% ethanol at Ϫ20°C. Annexin V specifically binds to phosphatidylserines externalized on apoptotic cells. For Apotag assays, cells were fixed in 1% paraformaldehyde for 20 min on ice and then stored in 80% EtOH at Ϫ20°C for at least 40 min, followed by incubation with terminal deoxynucleotide transferase and fluorescein isothiocyanate-dUTP per the manufacturer's directions. This reaction labels the double stranded DNA breaks characteristic of apoptotic cells. The second aliquot was pulsed for 30 min with 10 M BrdUrd (supplied in BrdUrd Flow Kit, Pharmingen), and the cells were fixed and stained with fluorescein isothiocyanate-conjugated anti-BrdUrd antibody per the manufacturer's directions. BrdUrd is incorporated by the nuclei of cells actively synthesizing DNA. Cells labeled by these procedures were resuspended in solution containing 20 g/ml propidium iodide (PI) and 60 l/ml DNase-free RNase for labeling of total DNA and analysis by flow cytometry. Cells were analyzed on a Becton Dickinson FACScan flow cytometer.
Statistics-Data were analyzed by Student's two-tailed t test for paired values.
RESULTS

TPO Activates PI3K and Akt in BaF3/Mpl Cells and in
Primary MKs-Activation of PI3K leads to the phosphorylation and activation of the serine/threonine kinase Akt, and thus the phosphorylation state of Akt serves as a marker for PI3K activity. In order to assess whether exposure of BaF3/Mpl cells and primary MKs to TPO results in activation of PI3K, we assayed phosphorylation of Akt. BaF3/Mpl cells were starved in serum-free, growth factor-free medium for 6 h in order to allow for maximum dephosphorylation of cellular proteins. Cells were then preincubated with a 0 (Me 2 SO only), 8, or 16 M PI3K inhibitor LY294002 in Me 2 SO. After 30 min, the cells were stimulated with rhTPO for 10 min, and whole cell protein lysates were prepared. Lysates were analyzed by Western blotting, using an antibody that is specific for the activated form of Akt that has been phosphorylated on Ser 473 . Blots were then reprobed with an antibody that recognizes all forms of Akt to verify equal loading. Although very little Akt was phosphorylated in unstimulated cells, treatment with TPO induced phosphorylation of Akt within 10 min. TPO-induced Akt phosphorylation was significantly reduced by preincubation with the specific PI3K inhibitor LY294002 (Fig. 1A) , confirming that phosphorylation of Akt was PI3K-dependent.
Similar experiments were performed using primary MKs; because the numbers of purified MK progenitors that can be obtained are limiting, mature MKs were used for this assay. Whole murine bone marrow cultures were incubated with recombinant mouse TPO for 3 days, and mature MKs were purified on a discontinuous albumin gradient. These cells were starved in serum-free, growth factor-free medium for 6 h; pretreated with 0, 8, or 16 M LY294002 for 30 min; and then stimulated for 10 min with rhTPO. Lysates were prepared and analyzed by Western blotting as described above. Treatment with TPO again induced phosphorylation of Akt within 10 min; phosphorylation was inhibited by pretreatment with LY294002 (Fig. 1B) . Thus, both in a Mpl-bearing cell line and in primary MKs, TPO induced activation of PI3K, which led to the phosphorylation of Akt.
TPO Stimulates Cell Cycling in BaF3/Mpl Cells and in Primary MK Progenitors by a PI3K-dependent Pathway-Be-
cause TPO stimulation resulted in the activation of PI3K, we next determined whether PI3K activity was important for cell cycling in response to TPO. In order to determine the optimal timing to determine the impact of LY294002 on TPO-induced cell cycling, a series of time course experiments were performed. We determined that after starvation, BaF3/Mpl cells required 12 h to enter the G 1 /S transition in response to stimulation by TPO and had obtained maximal numbers of cells in S phase at about 16 h, whereas cells cultured for longer than 24 h in the presence of LY294002 showed significant apoptosis (data not shown). Therefore, BaF3/Mpl cells were washed of growth factor and serum, starved for 6 h in RPMI containing 0.5% BSA, and then pretreated with 16 M LY294002 or Me 2 SO. At 16 h, cells were split into 2 aliquots and assayed in parallel for BrdUrd uptake and Apotag positivity as measures of cell cycling and viability. Apotag was chosen as a measure of apoptosis that would also yield information regarding DNA content and would be comparable in BaF3/Mpl cells and in MKs. Phosphatidylserine can be externalized in activated MKs, so there is a risk that it may not be specific for apoptosis in these cells. Fig. 2 shows flow cytometry results from a representative experiment of three performed. In the absence of LY294002, TPO induced brisk BrdUrd uptake compared with cells cultured without TPO (31% versus 3%; p ϭ 0.007). In the presence of LY294002, TPO-induced cell cycling was significantly inhibited, with only 12% of cells showing BrdUrd uptake (p ϭ 0.044 with and without LY294002). Notably, at this time point, TPO-induced cell survival was not significantly impaired by LY294002 (5% of cells were Apotag-positive, compared with 1% with TPO alone; p ϭ 0.42). From PI staining, it was determined that the majority of the BaF3/Mpl cells treated with LY294002 and TPO had a 2N DNA content (81% of surviving cells treated with TPOϩLY294002 in G 1 compared with 57% of cells treated with TPO alone; p ϭ 0.002; Fig. 3 survival, as it can be observed at a time when nearly all of the cells are viable. This suggests that TPO signals to the cell cycle machinery by a pathway involving PI3K that is separate from the PI3K-dependent pathway signaling cell survival.
In order to determine the importance of PI3K activity for TPO-induced cell survival and cell cycling in primary cells, we performed similar assays in MK progenitors. MK progenitors were chosen for analysis instead of mature MKs in order to examine TPO responses in cells of low ploidy classes, as cells in higher ploidy classes normally stop cycling and undergo physiologic apoptosis. Because MKs can undergo both mitotic and endomitotic cell cycling, which may be regulated differently, we sorted our starting population into 2N (mitotic) and 4N (potentially endomitotic) cells to more easily trace their progression in the cell cycle. CD41-positive cells were isolated from mouse marrow by lineage depletion and FACS and were sorted in to 2N and 4N populations based on Hoechst staining. Negative selection for Gr-1 improves ploidy distribution by excluding MKs with adherent neutrophils (62) . Diploid and 4N CD41ϩ cells were cultured in IMDM/10%FCS with 10 ng/ml rhTPO and 16 M LY294002 or Me 2 SO for 12 h. Cells were assayed for BrdUrd uptake Apotag positivity, as described above for BaF3/ Mpl cells. Fig. 4 shows flow cytometry results from a representative experiment (n ϭ 3). TPO promoted both mitotic and endomitotic cell cycling in 2N and 4N MK progenitors respectively, which was significantly inhibited in the presence of LY294002. LY294002-treated cells showed little TPO-induced BrdUrd uptake in cells either progressing from 2N to 4N or from 4N to 8N. Staining for DNA content with PI additionally showed that the majority of 2N MKs remained as 2N (i.e. in G 1 ), as seen in the BaF3/Mpl cells, whereas the majority of the 4N MKs remained as 4N, implying both a G 1 and a G 2 /M block. Simultaneous assays for Apotag (Fig. 5) showed that the majority of the MK progenitors were viable, although the frequency of Apotag positive cells was greater in MKs than in BaF3/Mpl cells, whether they were treated with TPO alone or with TPO and LY294002. In addition, 4N MKs appeared to be more susceptible to LY294002-induced apoptosis than were 2N MKs, although this difference was not significant. Therefore, TPO induces PI3K-dependent signals that are important for cell cycling both in a TPO-responsive cell line and in primary MK progenitors, resulting in a G 1 arrest in both cell types and possibly a G 2 /M arrest in MKs.
Expression of Constitutively Active Akt Prevents LY294002-induced Cell Cycle Block-Chemical kinase inhibitors may lack complete specificity for the target kinase. For example, some have shown that the use of LY294002 is associated with decreased phosphorylation of ERK (32, 33) , and LY294002 (and the other commonly used PI3K inhibitor, wortmannin) can inhibit the PI3K-like kinases such as ATM and PDK (34, 35) . Using our experimental conditions, we did not see any effect of LY294002 on TPO-induced ERK phosphorylation (data not shown). In order to demonstrate that the effects of LY294002 were due to inhibition of PI3K, we stably transfected BaF3/Mpl cells to express a form of Akt that is constitutively active by Cells were then cultured without TPO or with TPO in the absence or presence of LY294002 for 12 h. Cells were then processed either for BrdUrd uptake or for Apotag staining as described under "Materials and Methods," resuspended with PI, and analyzed by flow cytometry. Data shown compiled from six independent experiments (three assays for BrdUrd uptake and three assays for Apotag staining).
virtue of the addition of a myristylation site that confers PI3K-independent association with the plasma membrane. We then starved these cells (MyrAktMpl) along with their parent BaF3/ Mpl cells and cultured them for 16 h without TPO, with TPO, or with TPO and 16 M LY294002. We then assayed for BrdUrd uptake and Annexin positivity as measures of cell cycling and apoptosis. In the absence of TPO, MyrAktMpl cells had only marginally improved survival and BrdUrd uptake compared with the parent cells, and in the presence of TPO, their survival and BrdUrd uptake was equivalent to that of the parent cell line. However, MyrAktMpl cells cultured with TPO and LY294002 showed no impairment of cell cycling compared with the parent cell line, the BrdUrd uptake of which had decreased by at least half (Fig. 6A , flow cytometry results of a representative experiment on MyrAktMpl cells; Fig. 6B , summary of three experiments comparing MyrAktMpl cells and parental BaF3/Mpl cells). Thus, active Akt seems to be necessary but not sufficient for TPO-induced cell cycling. Furthermore, expression of this PI3K pathway member rescues cells from LY294002-induced cell cycle block, confirming the specificity of LY294002 for the PI3K pathway.
DISCUSSION
As research into cytokine signaling progresses, it is becoming apparent that a complex array of signals is directed by cytokines, which cooperate to amplify or modulate the cellular response. Cell survival signals in particular synergize with proliferative signals to provide maximal cell growth. TPO is known to stimulate cell growth through activation of the Jak/ STAT and Ras/Raf/MAPK pathways, although the specific contributions of these pathways to cell survival and cell cycling are not yet fully understood. In this work, we show that PI3K transduces a signal that promotes cell cycling in response to TPO both in a Mpl-bearing cell line and in primary MK progenitors and that that this signal can be distinguished from its effects on cell survival.
TPO is among many growth factors that have been shown to stimulate PI3K; however, the mechanism by which TPO activates PI3K is not understood. Mpl does not contain the YXXM or YVAC motifs, which are classically required to bind the SH2 domains of p85 (36) . In addition, attempts to immunoprecipitate p85 with Mpl have been unsuccessful (37) , suggesting that the interaction is indirect or of low affinity. It has been demonstrated that a complex forms between Gab-2 and SHP-2 that may mediate the activation of PI3K by TPO in BaF3/Mpl cells (11) .
Because our conclusions rely largely on the use LY294002, it is important to consider its specificity as an inhibitor of PI3K. LY294002 works by reversibly inhibiting the ability of PI3K to catalyze the transfer of phosphate from ATP to its substrate (22 such as DNA-PK and ATM, as well as casein kinase (34, 35, 38) ; although we have not looked directly for an effect on these other kinases, we have attempted to perform our assays at the lowest effective LY294002 doses. It is notable that the cell cycle block attributed to the inhibition of DNA-PK and ATM by LY294002 was reported to be in G 2 /M, due to the presence of unrepaired DNA breaks occurring after radiation (35) . Inhibitors of PI3K have also been noted to inhibit the distantly related kinase FRAP/TOR, which is an upstream regulator of p70 S6K and has been implicated in cell cycle regulation (39). We did not note, however, any effect on cell survival or cell cycling when treating cells with rapamycin (data not shown), which effectively inhibits TOR (40) , and expression of constitutively active Akt is sufficient to rescue MyrAktMpl cells from LY294002-induced cell cycle arrest and apoptosis. Finally, several reports indicate that inhibition of PI3K can result in reduced activation of MAPK (41) (42) (43) , whereas other reports indicate that inhibition of PI3K has no effect on activation of MAPK (22, 44) . In BaF3/Mpl cells, the concentrations of LY294002 that we employed did not result in significant inhibition of the MAPK pathway as measured by ERK phosphorylation; furthermore, specific inhibition of the MAPK pathway using PD98059 did not significantly reduce TPO-induced cell survival or cell cycling (data not shown). The fact that expression of a constitutively active Akt completely rescued TPOtreated BaF3/Mpl cells from the effects of LY294002, allowing them to cycle normally, provides a strong argument for both the specificity of LY294002 in PI3K signaling and the role of Akt in PI3K-dependent cell cycling and survival in response to TPO. Active Akt, however, was not sufficient to promote significant cell cycling and survival by itself, and a second TPO-dependent signal was required. Therefore, our results differ somewhat from those of others, who reported that constitutively active Akt could provide growth factor independence from IL-3 (18) or IL-4 (45) .
The role of PI3K in promoting cell survival is well documented (17-19, 46 -49) . In this work, we observed that PI3K is also required for TPO-induced cell cycling. We did observe increased apoptosis in response to the inhibition of PI3K, but the effects of LY294002 on cell cycling were evident as much as 16 h before significant apoptosis was measured by Annexin and Apotag assays. The mechanisms by which PI3K might promote cell proliferation are not known. Nevertheless, our data would suggest that in TPO signaling, PI3K activity is important for the cells to transit from G 1 to S phase in both mitotically (BaF3/Mpl cells and 2N MKs) and endomitotically (4N MKs) cycling cells. Endomitosis is a defining feature of maturing megakaryocytes that is thought to involve a specific defect in late anaphase, with the resulting failure of telophase and the development of large polyploid cells (50 -52) . Cells that become polyploid are theorized to have a functional advantage from increased size. The differences between G 1 of the mitotic cell cycle and the endomitotic cell cycle are not understood, but G 1 in endomitosis is significantly shorter and thus is likely to be regulated differently. In addition, the D-type cyclin in MKs is primarily cyclin D3, whereas much of the data in the literature pertains to cyclin D1 (53) (54) (55) (56) . G 1 arrest has been previously described in response to inhibition of PI3K in several nonhematopoietic cell types, and in these systems, it has been attributed to decreased cdk2 and cdk4 activities, decreased cyclin D1, and increased p27 kip (56 -58) . Activated Akt has been reported to increase the posttranslational stability of cyclin D1 through its inhibition of GSK-3␤ (58, 59) . In hematopoietic cells, PI3K signals were shown to be necessary and sufficient for stimulation of E2F activity by IL-2 in a T cell line (61) . Active Akt was shown to increase cyclin D1 and decrease p27 kip in this system; however, PI3K signals were not sufficient for cell cycling.
In summary, we have shown that TPO induces PI3K activity and that this activity is required for optimal cell survival and cell cycling in response to TPO, both in a factor-dependent leukemic cell line and in primary MK progenitors. The absence of PI3K activity results in a block in the cell cycle, which occurs in G 1 in BaF3/Mpl cells and results in absence of endomitosis in MK progenitors. Constitutively active Akt can replace the activity of PI3K in promoting cell cycling and cell survival, although without another non-PI3K TPO signal, it is not itself sufficient for cell growth, implying a requirement for a second signal from another pathway such as Jak/STAT or MAPK.
